Chongqing Taiji Industry Group Co Ltd banner
C

Chongqing Taiji Industry Group Co Ltd
SSE:600129

Watchlist Manager
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Watchlist
Price: 17.69 CNY 0.68% Market Closed
Market Cap: ¥9.8B

Chongqing Taiji Industry Group Co Ltd
Investor Relations

Amidst the sprawling urban landscape of Chongqing, a city often enveloped in a mystical cloak of fog, stands Chongqing Taiji Industry Group Co Ltd., a distinguished entity in the realm of pharmaceuticals. Commanding a legacy that spans over a century, Taiji Industry has mastered the delicate fusion of traditional Chinese medicine with modern pharmaceutical processes. This synthesis has propelled the company to the forefront of China's healthcare sector. The company’s operations revolve around robust research and development, manufacturing, and distribution, focusing on a diverse array of pharmaceutical products, health supplements, and TCM (Traditional Chinese Medicine) remedies. Seamlessly integrating innovation with traditional wisdom, the group has built an extensive portfolio catering to a wide range of medical needs, from cardiovascular treatments to neurological supports.

Financially, Taiji Industry's prowess is underpinned by its diverse revenue streams, primarily flowing from its broad spectrum of medicinal drugs and health products. The company has capitalized on its established brand and extensive distribution networks, which span across the vast Chinese landscape and extend their reach into international markets. Their stronghold in distribution is further solidified by strategic collaborations with healthcare providers and retail pharmacy chains, ensuring reliable market penetration and accessibility to the end consumer. This well-oiled machine not only secures Taiji's position as a major pharmaceutical player but also drives its financial growth, allowing the company to invest continuously in innovation, quality enhancement, and market expansion. The synergistic blend of tradition and modernity continues to propel Taiji Industry through the ever-evolving pharmaceutical landscape.

Show more
Loading
600129
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Min Yu
GM & Director
No Bio Available
Mr. Zunyi Liu
Chief Financial Officer
No Bio Available
Mr. Zhongxi Zhang
Deputy GM & Director
No Bio Available
Ms. Qian Jiang
Deputy GM & Secretary of the Board of Directors
No Bio Available
Mr. Shisui Luo
Deputy General Manager
No Bio Available

Contacts

Address
CHONGQING
Chongqing
No.18, Hengshan East Road, Yubei District
Contacts
+862389886129
www.taiji.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett